Weil Company’s Amgen AMGN Stock Holding History

Weil Company’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,262	Closed	-$284K	–	126
2021 Q4	$284K	Buy	+1,262	New	+$266K	0.13%	114
2020 Q3	–	Sell	-2,242	Closed	-$529K	–	114
2020 Q2	$529K	Sell	2,242 -270	-11%	-$61.6K	0.45%	52
2020 Q1	$509K	Sell	2,512 -104	-4%	-$22.7K	0.48%	46
2019 Q4	$631K	Sell	2,616 -506	-16%	-$112K	0.48%	46
2019 Q3	$604K	Hold	3,122	–	–	0.45%	46
2019 Q2	$575K	Buy	3,122 +40	+1%	+$7.16K	0.47%	47
2019 Q1	$586K	Sell	3,082 -1,000	-24%	-$191K	0.49%	51
2018 Q4	$795K	Hold	4,082	–	–	0.72%	34
2018 Q3	$799K	Hold	4,082	–	–	0.66%	38
2018 Q2	$753K	Hold	4,082	–	–	0.64%	41
2018 Q1	$696K	Hold	4,082	–	–	0.65%	41
2017 Q4	$710K	Buy	+4,082	New	+$722K	0.65%	41

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Weil Company's AMGN Position: Q1 2022 in Review

Weil Company sold out of Amgen (AMGN) in Q1 2022, closing a stake of 1,262 shares — an estimated $284K sold.

Weil Company first reported a position in AMGN in Q4 2017 and held it in 12 quarters. The position peaked at $799K in Q3 2018. 2,337 funds tracked by Wall St. Rank hold AMGN as of Q1 2022.

Weil Company reported no remaining Amgen position as of Q1 2022 after selling out during the quarter.
Weil Company sold 1,262 Amgen shares in Q1 2022, an estimated $284K.
Weil Company first reported a position in Amgen in Q4 2017 and held it in 12 quarters.
Weil Company's Amgen position peaked at $799K in Q3 2018.
2,337 funds tracked by Wall St. Rank held Amgen as of Q1 2022.

Based on Weil Company's 13F filing for Q1 2022, filed 6 May 2022.